Download
https://www.ndtvprofit.com/business/zydus-lifesciences-q3-review-shares-gain-after-profit-beats-estimates?utm_source=telegram&utm_medium=referral&utm_campaign=socialshare
Most analysts maintain "buy" ratings on Zydus Lifesciences on the expectation of double-digit growth in India.
Share